Category
Neurosciences
Sub Category
Stroke
Study Name
Respect ESUS:Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate (110 mg or 150 mg, oral b.i.d.) versus acetylsalicylic acid (100 mg oral q.d.) in patients with Embolic Stroke of Undetermined Source (RESPECT ESUS)
Principal Investigator
John Ip, MD
Study Information
Patients at risk for a second stroke
Contact for Questions
517-364-5760

Site view: at a glance